Effectiveness of a short-term group psychotherapy program on endocrine and immune function in breast cancer patients: An exploratory study

被引:66
作者
vanderPompe, G [1 ]
Duivenvoorden, HJ [1 ]
Antoni, MH [1 ]
Visser, A [1 ]
Heijnen, CJ [1 ]
机构
[1] HELEN DOWLING INST BIOPSYCHOSOCIAL MED,ROTTERDAM,NETHERLANDS
关键词
group psychotherapy program; endocrines; immune function; breast cancer;
D O I
10.1016/S0022-3999(96)00393-5
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Cancer patients who had been treated for early stage breast cancer and were diagnosed with either positive axillary lymph nodes or distant metastases were randomly assigned to either a 13-week experiential-existential group psychotherapy (EEGP) program or a waiting list control (WLC) condition. Endocrine and immune measures were obtained before and after the intervention period. The findings of this study are that, after the 13 weeks of the experiment, patients in the EEGP group showed lower levels of plasma cortisol and lower levels of prolactin as well as lower percentages of natural killer cells, CD8 cells, and CD4 cells in addition to a lower proliferative response to pokeweed mitogen than patients in the WLC group. Importantly, this was only found in those breast cancer patients presenting relatively high endocrine and immune baseline levels, suggesting that the patients' profile with regard to endocrine and immune function at the start of a program can have an important effect. If replicated on a larger scale, the current results may be relevant for the treatment of breast cancer. (C) 1997 Elsevier Science Inc.
引用
收藏
页码:453 / 466
页数:14
相关论文
共 41 条
[1]  
ANDERSEN B, 1992, JCCP, V66, P552
[2]  
BARON GC, 1985, DIAGN CLIN IMMUNOL, V3, P197
[3]   Does surgery disseminate or accelerate cancer? [J].
Baum, M .
LANCET, 1996, 347 (8996) :260-260
[4]   AN INVENTORY FOR MEASURING DEPRESSION [J].
BECK, AT ;
ERBAUGH, J ;
WARD, CH ;
MOCK, J ;
MENDELSOHN, M .
ARCHIVES OF GENERAL PSYCHIATRY, 1961, 4 (06) :561-&
[5]   MODULATION OF NATURAL-KILLER CELL-ACTIVITY BY TAMOXIFEN IN STAGE-I POSTMENOPAUSAL BREAST-CANCER [J].
BERRY, J ;
GREEN, BJ ;
MATHESON, DS .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1987, 23 (05) :517-520
[6]   WHOLE-BLOOD LYMPHOCYTE-CULTURES [J].
BLOEMENA, E ;
ROOS, MTL ;
VANHEIJST, JLAM ;
VOSSEN, JMJJ ;
SCHELLEKENS, PTA .
JOURNAL OF IMMUNOLOGICAL METHODS, 1989, 122 (02) :161-167
[7]  
BOUMAN TK, 1985, GEDRAG GEZOND, V13, P13
[8]  
BRENNER BG, 1991, CANCER-AM CANCER SOC, V68, P482, DOI 10.1002/1097-0142(19910801)68:3<482::AID-CNCR2820680306>3.0.CO
[9]  
2-9
[10]   PHYTOHEMAGGLUTININ RESPONSIVENESS OF PERIPHERAL LYMPHOCYTES AND SURVIVAL IN PATIENTS WITH PRIMARY BREAST-CANCER [J].
BURFORDMASON, A ;
GYTE, GML ;
WATKINS, SM .
BREAST CANCER RESEARCH AND TREATMENT, 1989, 13 (03) :243-250